CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combos tested for common adult leukemia in japan
Disease control CompletedThis study tested two different drug combinations for Japanese adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), which are types of blood cancer. About 20 participants were assigned to receive either venetoclax with obinutuzu…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug combo challenges standard chemo for blood cancer
Disease control CompletedThis completed Phase 3 trial compared a newer drug combination (venetoclax + obinutuzumab) against standard chemotherapy regimens for adults with previously untreated chronic lymphocytic leukemia (CLL). The goal was to see which approach was more effective at controlling the canc…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC